Orgenesis Inc (NASDAQ:ORGS) has entered into a definitive agreement with MM OS Holdings, an affiliate of Metalmark Capital Partners, to acquire its approximate 25% stake in Octomera. Octomera is Orgenesis’s cell processing services subsidiary, and the transaction allows the company to have 100% ownership of this business unit. In exchange, Metalmark will receive a royalty of 5% of the net revenue of Octomera’s cell processing services for the three calendar years 2025-2027, along with a portion of the proceeds attributable to Octomera’s cell processing services should there be a change of cont…
